SAMANTHA KRATOFIL: Open Payments
NPI 1487482147 · HAMILTON, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Organogenesis Inc. | 1 | $40 |
| Amgen Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: FANAPT, CYGNUS DUAL, OTEZLA, REXULTI, INSPIRE, Ozempic, AIRSUPRA, VRAYLAR.
Industry payments across MT — which companies pay providers there.
